Pharmacotherapy of bronchopulmonary dysplasia: A personalized approach

The lecture, based on relevant international and domestic consensus documents, research results, and authors' experience, provides relevant information on personalized pharmacotherapy of bronchopulmonary dysplasia (BPD), including the use of drugs of such groups as systemic and inhaled glucocorticosteroids, methylxanthines, inhaled bronchodilators, diuretics. It provides modern definition of the disease and its diagnostic criteria, goals of therapy. Indications, treatment regimens, dosages, contraindications and side effects of drugs of these groups in children with BPD of different ages at different stages of treatment and observation are described. © 2020, Pediatria Ltd.. All rights reserved.

Authors
Ovsyannikov D.Y. 1 , Boitsova E.V.2 , Pavlinova E.B.3 , Zhestkova M.A. 1 , Semyatov S.M. 1
Number of issue
2
Language
Russian
Pages
216-222
Status
Published
Volume
99
Year
2020
Organizations
  • 1 Peoples’ Friendship University of Russia, Moscow, Russian Federation
  • 2 St. Petersburg State Pediatric Medical University, St. Petersburg, Russian Federation
  • 3 Omsk State Medical University, Omsk, Russian Federation
Keywords
Bronchopulmonary dysplasia; Medicines; Personalized approach; Prevention; Therapy
Date of creation
02.11.2020
Date of change
02.11.2020
Short link
https://repository.rudn.ru/en/records/article/record/64935/